Alpha Cognition Inc. (ACOG)

Kritische 8-K Meldungen

Datum	Meldung	Schwere	Filing	Auszug
15.01.2026	Item 5.02 — Abgang Schlüsselpersonen	HOCH	SEC	Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Comp
23.06.2025	Item 5.02 — Abgang Schlüsselpersonen	HOCH	SEC	Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
27.02.2025	Item 5.02 — Abgang Schlüsselpersonen	HOCH	SEC	Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
24.10.2024	Item 5.02 — Abgang Schlüsselpersonen	HOCH	SEC	Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
09.10.2024	Item 5.02 — Abgang Schlüsselpersonen	HOCH	SEC	Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; C

Stammdaten

Alpha Cognition Inc., a clinical stage biopharmaceutical company, engages in the development of treatments for Alzheimer's disease and amyotrophic lateral sclerosis (ALS). The company offers ZUNVEYL (benzgalantamine) for the treatment of mild-to-moderate Alzheimer's disease and mild traumatic brain injury. It also develops ALPHA-0602, a gene therapy for the treatment of ALS; and ALPHA-0702 and ALPHA-0802, a granulin epithelin motifs for the treatment of neurodegenerative diseases. The company was formerly known as Crystal Bridge Enterprises Inc. and changed its name to Alpha Cognition Inc. in March 2021. Alpha Cognition Inc. was founded in 2000 and is headquartered in Vancouver, Canada.

Unternehmen & Branche

Name	Alpha Cognition Inc.
Ticker	ACOG
CIK	0001655923
Boerse	US
Sektor	Financial Services
Industrie	Financial - Conglomerates
SIC	2836 · Biological Products, (No Diagnostic Substances)

Wertpapier & Kennzahlen

CUSIP	–
ISIN	–
Typ	Common Stock
Marktkapitalisierung	95,1 Mio. USD
Beta	2,52
Dividendenrendite	0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

Periode	Filing	Umsatz	Nettoergebnis	EPS	Aktiva	Eigenkapital
2025-12-31	10-K	10,220,275	-20,669,875	-1.18	79,730,235	62,530,175
2025-09-30	10-Q	2,840,858	-1,318,074	-0.30	46,301,213	33,913,810
2025-06-30	10-Q	1,657,687	-10,488,952	-0.65	45,122,942	31,896,316
2025-03-31	10-Q	2,928,654	-2,006,543	-0.13	48,608,419	40,811,875
2024-12-31	10-K		-14,788,727	-2.04	50,736,938	39,094,827
2024-09-30	10-Q		-1,859,906	-0.31	5,028,072	-2,569,399
2024-06-30	10-Q		-2,115,512	-0.35	2,082,002	1,043,234
2024-03-31	10-Q		-5,002,711	-0.87		535,151
2023-12-31	10-K		-13,763,658	-3.84	2,452,170	-4,703,695
2023-09-30	10-Q		-3,269,123	-0.84		-6,193,241
2023-06-30	10-Q		-2,817,574	-0.03		-579,426
2015-03-31	10-K	100,000,000

Fondsaktivität (Vorquartalsvergleich)

Keine Fondsdaten für dieses Unternehmen vorhanden.

Insider-Transaktionen (12 Monate)

Datum	Insider	Rolle	Typ	Stückzahl	Kurs	Wert (USD)	Δ
2026-03-30	Opaleye Management Inc.	10% Owner	Open Market Purchase	1,850	4.99	9,226.51	+9,7%
2026-03-27	Opaleye Management Inc.	10% Owner	Open Market Purchase	10,000	5.08	50,792.00	+53,4%
2026-03-26	Opaleye Management Inc.	10% Owner	Open Market Purchase	7,319	5.28	38,675.06	+40,7%
2026-03-25	Opaleye Management Inc.	10% Owner	Open Market Purchase	8,581	5.43	46,578.53	+49,0%
2026-03-24	Opaleye Management Inc.	10% Owner	Open Market Purchase	4,182	5.59	23,377.38	+24,6%
2026-03-19	Opaleye Management Inc.	10% Owner	Open Market Purchase	2,094	5.71	11,950.46	+12,6%
2026-03-18	Opaleye Management Inc.	10% Owner	Open Market Purchase	2,481	5.75	14,263.27	+15,0%
2026-03-16	Opaleye Management Inc.	10% Owner	Open Market Purchase	1,331	5.78	7,695.84	+8,1%
2026-03-13	Opaleye Management Inc.	10% Owner	Open Market Purchase	7,358	5.75	42,286.43	+44,5%
2026-03-12	Opaleye Management Inc.	10% Owner	Open Market Purchase	5,708	5.85	33,416.34	+35,1%
2026-03-09	Opaleye Management Inc.	10% Owner	Open Market Purchase	2,179	5.85	12,742.14	+13,4%
2026-03-06	Opaleye Management Inc.	10% Owner	Open Market Purchase	1,900	5.80	11,017.91	+11,6%
2026-03-05	Opaleye Management Inc.	10% Owner	Open Market Purchase	42,023	5.80	243,632.54	+256,2%
2026-03-05	Opaleye Management Inc.	10% Owner	Open Market Purchase	5,000	5.80	28,988.00	+30,5%
2026-03-04	Opaleye Management Inc.	10% Owner	Open Market Purchase	19,795	5.81	115,001.03	+120,9%
2026-03-03	Opaleye Management Inc.	10% Owner	Open Market Purchase	5,000	5.75	28,751.00	+30,2%
2026-03-03	Opaleye Management Inc.	10% Owner	Open Market Purchase	46,411	5.75	266,872.53	+280,6%
2026-03-02	Opaleye Management Inc.	10% Owner	Open Market Purchase	20,000	5.80	116,000.00	+122,0%
2026-02-27	Opaleye Management Inc.	10% Owner	Open Market Purchase	3,638	5.99	21,797.08	+22,9%
2026-02-26	Opaleye Management Inc.	10% Owner	Open Market Purchase	590	5.99	3,531.15	+3,7%
2026-02-24	Opaleye Management Inc.	10% Owner	Open Market Purchase	5,000	5.80	29,002.00	+30,5%
2026-02-24	Opaleye Management Inc.	10% Owner	Open Market Purchase	53,591	5.80	310,849.24	+326,9%
2026-02-23	Opaleye Management Inc.	10% Owner	Open Market Purchase	95,819	5.89	564,594.29	+593,7%
2026-02-23	Opaleye Management Inc.	10% Owner	Open Market Purchase	4,181	5.89	24,635.71	+25,9%
2026-02-20	Opaleye Management Inc.	10% Owner	Open Market Purchase	10,000	5.84	58,411.00	+61,4%
2026-02-20	Opaleye Management Inc.	10% Owner	Open Market Purchase	2,819	5.84	16,466.06	+17,3%
2025-08-18	MERTZ LEONARD POWELL	Director	Open Market Purchase	27,778	9.00	250,002.00	+262,9%
2025-08-18	Wills Robert James	Director	Open Market Purchase	15,000	8.49	127,327.50	+133,9%
2025-08-18	MERTZ PHILLIP JOSEPH	Director	Open Market Sale	-27,778	9.00	-250,002.00	-262,9%

Top-Fondshalter

Keine Fondsdaten zu dieser Aktie vorhanden.